Healthier Populations, Everywhere

We are value driven, not just in the sense of the values we adhere to, but also in the solutions we offer. We provide informed advice and services along the entire life cycle of products and health programmes - from upstream development to downstream programmes, including the surveillance of diseases within communities, policy making, and the forecasting of vaccine supply.

Filters

Region
Region
  • Africa
  • Americas
  • Europe
  • Oceania
Country
Country
  • Albania
  • Armenia
  • Bangladesh
  • Barbados
  • Belarus
  • Benin
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Cambodia
Focus Areas
Projects - Focus Areas
  • Access
  • Evaluation
  • Implementation
  • Policy & Strategy
Vaccine Preventable Diseases
Projects - Vaccine Preventable Diseases
  • Cholera
  • COVID-19
  • Diphtheria
  • Enteric Fever
  • Human Papillomavirus
  • Influenza
  • Japanese Encephalitis
  • Leishmaniasis
  • Measles-Rubella
  • Meningitis
Client
Projects - Clients
  • Asian Development Bank
  • Bill & Melinda Gates Foundation
  • Centers for Disease Control and Prevention (CDC)
  • Christian Medical College
  • Coalition for Epidemic Preparedness Innovation (CEPI)
  • EU Commission
  • Gavi, The Vaccine Alliance (Gavi)
  • Global Task Force on Cholera Control (GTFCC)
  • Inter American Development Bank
  • ISGlobal
Search
Sort By (Projects)
  • Focus Project
2021 — 2024

Pilot approaches to develop national cholera plans and assist the Global Task Force on Cholera Control to implement oral cholera vaccination

Support countries to use an existing tool to estimate the costs and benefits of implementing the Ending Cholera Roadmap 2030 and support WHO to develop an oral cholera vaccination (OCV) deployment strategy.

Client
Bill & Melinda Gates Foundation
  • Focus Project
2022 — 2022

Develop an operational framework for the European Immunization Agenda 2030

Support the WHO European Regional Office to operationalize the European Immunization Agenda 2030 (EIA2030).

Client
World Health Organisation (WHO)
  • Focus Project
  • New Format
2021 — 2023

Develop country training materials on the preparation, implementation and monitoring of OCV campaigns

Develop and pilot technical training materials for oral cholera vaccination (OCV) campaigns.

Client
Centers for Disease Control and Prevention (CDC)
  • New Format
2022 — 2023

Papua New Guinea full immunisation and health system strengthening portfolio planning

Support Papua New Guinea’s application for an immunization and health system strengthening grant.

Client
Gavi, The Vaccine Alliance (Gavi)
  • New Format
2022 — 2022

Ghana malaria vaccine application support

Support Ghana to continue and expand malaria vaccination.

Client
Gavi, The Vaccine Alliance (Gavi)
  • New Format
2021 — 2022

Papua New Guinea measles and rubella vaccine campaign 

Support Papua New Guinea to apply for Gavi funding for a measles and rubella immunization campaign.

Client
Gavi, The Vaccine Alliance (Gavi)
  • New Format
2022 — 2022

Improving health worker learning and performance management

Assist Gavi, the Vaccine Alliance in developing a vision and strategic direction for improving health worker learning and performance.

  • New Format
2018 — 2019

Preparing for implementation of the Ending Cholera Roadmap 2030

Support the Global Task Force on Cholera Control to implement the Ending Cholera: A Roadmap to 2030 by creating guidance to assist the development of country cholera strategies.

Client
Global Task Force on Cholera Control (GTFCC)
  • New Format
2019 — 2019

Improving vaccine access in the South-Eastern Europe Health Network (SEEHN)

Improving vaccine access in South-Eastern Europe Health Network member states through an improved knowledge base and procurement strategies.

Client
World Health Organisation (WHO)
Image Credit: MMGH/Thomas Cherian
  • New Format
2018 — 2019

Framework for the establishment of a programme performance monitoring unit in Myanmar

Support to the Myanmar Ministry of Health to strengthen leadership, management and coordination of public health programmes.

Client
Gavi, The Vaccine Alliance (Gavi)
2021 — Ongoing

Papua New Guinea Measles & Rubella campaign

MMGH is supporting Papua New Guinea in applying for Gavi funds needed to plan and implement a Measles & Rubella (MR) follow-up campaign. The campaign will also include a routine immunisation strengthening component as well as catch-up for zero-dose children, notably in hard to reach areas.

Client
Gavi, The Vaccine Alliance (Gavi)
Image Credit: MMGH/Carsten Mantel
2019 — 2019

Application for Gavi support for human papillomavirus vaccine introduction in Cambodia

MMGH assisted the National Immunisation Program (NIP), Ministry of Health Cambodia, and the WHO Country Office in Phnom Penh with the Gavi application process for the introduction of the human papillomavirus (HPV) vaccine. MMGH conducted a review of the earlier pilot programme implementation and derived lessons learned, facilitated the decision-making of the country Technical Working Group for Health on defining target age groups and delivery settings, and assisted in establishing detailed implementation plans including coverage monitoring, cold chain expansion, communications and demand creation. MMGH supported the NIP in responding to additional queries throughout the Gavi approval process as well as in developing robust vaccine demand forecasts and financial budgets in view of the country’s imminent transition from Gavi support. The application was approved by the Gavi Independent Review Committee (IRC) in March 2019.

Client
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2018 — 2018

Development of a comprehensive Multi-Year Plan in Lao PDR

MMGH supported the Ministry of Health and the WHO Country Office of Lao PDR in the review of the National Immunisation Program (NIP) and the establishment and update of a comprehensive multi-year plan (cMYP) for 2019-2023. This plan specifically lays out the implementation and monitoring of existing and new vaccines and provides detailed insights into the financial needs and resource allocations in view of the country’s upcoming graduation from donor support.

Client
World Health Organisation (WHO)
2018 — 2018

Training the trainer for pandemic influenza preparedness

MMGH supported the WHO Department of Infectious Hazard Management (IHM) in the preparation and facilitation of a workshop on country preparedness for vaccine deployment in the event of an influenza pandemic. The main objective was to create a network of international experts that would be able to support their own country, and other countries, to develop national pandemic preparedness plans, and for participants to become educators about the need for countries to be prepared for a pandemic. MMGH revised and updated the WHO “Guidance on Development of a National Deployment and Vaccination Plan for Pandemic Influenza Vaccines” together with its associated Checklist, as well as all necessary workshop materials.

Client
World Health Organisation (WHO)
2017 — 2018

Influenza vaccine post-introduction evaluation (IPIE) in middle-income countries

A tablet-based Influenza Vaccine Post-Introduction Evaluation (IPIE) tool was developed by MMGH jointly with WHO, the U.S. Centers for Disease Control and Prevention (CDC) and the Swiss Tropical and Public Health Institute to provide a systematic approach to assess the influenza vaccine implementation process. The tool was used in three middle-income countries: Belarus, Morocco and Thailand. Data from the three countries highlighted a number of critical factors related to: health workers as a target group and as key influencers; unique challenges for acceptance of the vaccine in pregnant women; and the need for strengthening adverse events reporting and of potential vaccine hesitancy. The assessments led to improvements in the countries’ influenza vaccination programmes. The IPIE tool was found useful for delineating operational strengths and weaknesses of seasonal influenza vaccination programmes.

Client
World Health Organisation (WHO)
Image Credit: Lorenzo Pezzoli
2017 — 2017

Definition of the governance setup, funding framework and costing for the new strategy Ending Cholera: A Global Roadmap to 2030

MMGH supported the Global Task Force for Cholera Control in the definition of the new Cholera Control strategy. MMGH focused on the design of the governance and funding framework, as well as the costing of the Democratic Republic of Congo case study. The strategy was endorsed in October 2017 by the Cholera Stakeholders meeting in Annecy.

Client
World Health Organisation (WHO)
Image Credit: MMGH/Carsten Mantel
2017 — 2017

Application for Gavi support for Human Papillomavirus and Rotavirus vaccine introduction in Lao PDR

MMGH supported the Ministry of Health and the WHO Country Office of Lao PDR in developing two successful Gavi applications for the introduction of Human Papillomavirus and Rotavirus vaccines.

Client
World Health Organisation (WHO)
Image Credit: MMGH/Stefano Malvolti
2018 — 2018

Definition of a capacity building plan for Gavi’s Country Programmes department

MMGH supported the Country Programmes department of the Gavi Secretariat in defining its competency model and related training programmes. Partnering with Gavi’s Human Resource and Knowledge Management department and conducting focus group discussions, MMGH identified the key elements of the model and designed assessment tools and a training curriculum.

Client
Gavi, The Vaccine Alliance (Gavi)